Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

MEDIAN TECHNOLOGIE. News

Aktie
WKN:  A1JCLB ISIN:  FR0011049824 Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Frankreich
4,93 €
-0,01 €
-0,20%
17.04.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
75,70%
KGV
-2,82
Index-Zuordnung
-

MEDIAN TECHNOLOGIE. News

07.04.26 - Businesswire
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2026
Regulatory News:
18.03.26 - Businesswire
Median Technologies Achieves ISO 13485:2016 Certification for eyonis® Medical Device Quality Management System
Regulatory News:
13.03.26 - Businesswire
Median Technologies Meets the Eligibility Conditions for the PEA-PME Scheme
Regulatory News:
09.03.26 - Businesswire
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2026
Regulatory News:
02.03.26 - Businesswire
Median Technologies to Showcase eyonis® LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology
Regulatory News:
27.02.26 - Businesswire
Median Technologies to present at the TD Cowen 46th Annual Health Care Conference
Regulatory News:
23.02.26 - Businesswire
Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis® LCS
Regulatory News:
18.02.26 - Businesswire
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.
Regulatory News:
12.02.26 - Businesswire
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
Regulatory News:
11.02.26 - Businesswire
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026
Regulatory News:
09.02.26 - Businesswire
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening
Regulatory News:
19.01.26 - Businesswire
Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026
Regulatory News:

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »